You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 7, 2024

Claims for Patent: 8,404,927


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,404,927
Title:Double-stranded RNA stabilized in planta
Abstract: This invention discloses recombinant DNA constructs that transcribe to RNA having improved resistance to a plant RNase III enzyme, and methods for their use in making transgenic plant cells, plants, seeds, and products derived therefrom. Also provided are compositions and methods for imparting to a plant resistance to a pest or pathogen of the plant.
Inventor(s): Allen; Edwards (O\'Fallon, MO), Gilbertson; Larry A. (Chesterfield, MO), Krieger; Elysia K. (Kirkwood, MO), Roberts; James K. (Chesterfield, MO), Staub; Jeffrey M. (Wildwood, MO)
Assignee: Monsanto Technology LLC (St. Louis, MO)
Application Number:11/453,155
Patent Claims:1. A recombinant DNA construct for plant cell transformation, comprising transcribable DNA that transcribes to a single RNA for silencing one or more target genes of a pest or pathogen of a plant, said DNA comprising operably linked two or more non-identical pairs of self-complementary sequences of said target genes, wherein said RNA comprises double-stranded RNA and has a stabilizing feature comprising multiple double-stranded RNA stems, said multiple double-stranded RNA stems comprising two or more non-identical pairs of self-complementary sequences, said stabilizing feature imparting improved resistance to a plant Dicer or Dicer-like enzyme relative to an RNA lacking said stabilizing feature, and wherein said one or more target genes of a pest or pathogen of a plant comprises a vacuolar ATPase gene, wherein the construct comprises SEQ ID NO:16 or SEQ ID NO: 17, wherein said pest or pathogen of a plant is a Diabrotica species.

2. The recombinant DNA construct of claim 1, further comprising at least one of: (a) a plant promoter (b) a ribozyme flanking said transcribable DNA; (c) an intron, in which said transcribable DNA is embedded; (d) DNA that transcribes to an RNA aptamer capable of binding to a ligand; (e) DNA that transcribes to an RNA aptamer capable of binding to a ligand and DNA that transcribes to regulatory RNA capable of regulating expression of a target sequence, wherein said regulation is dependent on the conformation of said regulatory RNA, and said conformation of said regulatory RNA is allosterically affected by the binding state of said RNA aptamer; (f) at least one gene expression element; and (g) at least one T-DNA border.

3. A transgenic plant cell having in its genome the recombinant DNA construct of claim 1.

4. A transgenic plant containing the transgenic plant cell of claim 3.

5. Transgenic seed having in its genome the recombinant DNA construct of claim 1.

6. A method of providing a transgenic plant having improved resistance to a pest or pathogen of said plant, comprising: (a) providing the transgenic plant cell of claim 3, (b) growing a transgenic plant from said transgenic plant cell, and (c) transcribing said recombinant DNA construct in said transgenic plant, thereby conferring improved resistance to said pest or pathogen in said transgenic plant, relative to a plant in which said recombinant DNA construct is not transcribed.

7. The method of claim 6, wherein said transgenic plant is a transgenic maize plant and said Diabrotica species is Western corn rootworm.

8. A method of imparting to a plant resistance to a pest or pathogen of said plant, comprising (a) transforming said plant with the recombinant DNA construct of claim 1; (b) transcribing said recombinant DNA construct in said transformed plant; and (c) providing to at least one tissue of said transformed plant at least one of an insect control agent or a nematode control agent, thereby imparting to said transformed plant resistance to a pest or pathogen of said plant.

9. The method of claim 8, wherein said plant is a transgenic maize plant, and said Diabrotica species is Western corn rootworm.

10. The recombinant DNA construct of claim 1, comprising operably linked multiple anti-sense DNA segments that are anti-sense to at least one segment of one of said one or more target genes and multiple sense DNA segments that are the same as at least one segment of one of said one or more target genes, and wherein when said recombinant DNA construct is transcribed to a single RNA, said multiple anti-sense DNA segments and the multiple sense DNA segments are transcribed to form multiple double-stranded RNA stems.

11. The recombinant DNA construct of claim 10, wherein said multiple double-stranded stems are arranged to form at least one structure selected from the group consisting of a two-stem structure and a three or more-stem structure.

12. The recombinant DNA construct of claim 10, further comprising spacer DNA segments, wherein said spacer DNA segments are located between multiple anti-sense DNA segments or multiple sense DNA segments, and said spacer DNA segments are located within double-stranded stems when said transcribable DNA is transcribed to an RNA.

13. The recombinant DNA construct of claim 10, further comprising spacer DNA segments, wherein said spacer DNA segments are located between a base-pairing anti-sense DNA segment and a sense DNA segment, and said spacer DNA segments are located outside of double-stranded stems when said transcribable DNA is transcribed to an RNA.

14. The recombinant DNA construct of claim 13, wherein said spacer DNA segments form a loop region of sense or of anti-sense or of unrelated RNA sequence, separating a pair of inverted repeats.

15. The recombinant DNA construct of claim 10, comprising an anti-sense DNA segment followed by a sense DNA segment for a first target gene, and a sense DNA segment followed by an anti-sense DNA segment for a second target gene, wherein said first and second target genes are either the same or different.

16. The recombinant DNA construct of claim 15, further comprising a first spacer DNA segment between said anti-sense DNA segment and sense DNA segment for the first target gene, and a second spacer DNA segment between said sense DNA segment and anti-sense DNA segment for the second target gene, wherein said first and second spacer DNA segments form a first and second loop when transcribed.

17. Progeny of a transgenic plant according to claim 4, said progeny having in its genome said recombinant DNA construct.

18. The method of claim 8, wherein said resistance to a pest or pathogen of said plant is greater than the sum of (a) resistance obtained by transcribing in at least one cell of said plant DNA that transcribes to RNA for silencing a target gene of a pest or pathogen of a plant, wherein said RNA comprises double-stranded RNA and has a stabilizing feature comprising multiple double-stranded RNA stems, said stabilizing feature imparting improved resistance to a plant Dicer or Dicer-like enzyme relative to an RNA lacking said stabilizing feature, and (b) resistance obtained by providing to at least one tissue of said plant at least one of an insect control agent or a nematode control agent.

19. The method of claim 9, wherein said at least one of an insect control agent comprises a Bacillus thuringiensis insecticidal endotoxin.

20. The recombinant DNA construct of claim 11, wherein said two stem structure is selected from the group consisting of a hammerhead structure, a barbell structure, a dog bone structure, and a structure having "kissing stem loops".

21. The recombinant DNA construct of claim 11, wherein said three or more stem structure is selected from the group consisting of a cloverleaf structure and a pseudoknot-like structure.

22. The recombinant DNA construct of claim 10, comprising in operable linkage a first anti-sense DNA segment, a first spacer DNA segment, a first sense DNA segment, a second sense DNA segment, a second spacer DNA segment, and a second anti-sense DNA segment, wherein transcription of said recombinant DNA construct produces a first double-stranded RNA stem for suppressing a first target gene and a second double-stranded RNA stem for suppressing a second target gene.

23. The recombinant DNA construct of claim 10, comprising in operable linkage a first anti-sense DNA segment, a first spacer DNA segment, a first sense DNA segment for a first sequence of said one or more target genes, a second sense DNA segment, a second spacer DNA segment, and a second anti-sense DNA segment for a second sequence of said one or more target genes, wherein transcription of said recombinant DNA construct produces two double-stranded RNA stems for suppressing said one or more target genes.

24. The recombinant DNA construct of claim 1, wherein said Diabrotica species is Western corn root worm.

25. A recombinant DNA construct comprising operably linked multiple anti-sense DNA segments that are anti-sense to multiple target sequences of a vacuolar ATPase gene and multiple sense DNA segments that are the same as said multiple target sequences, wherein when said recombinant DNA construct is transcribed to a single RNA, said multiple anti-sense DNA segments and the multiple sense DNA segments are transcribed to form multiple double-stranded RNA stems comprising two or more non-identical pairs of self-complementary sequences of said vacuolar ATPase gene wherein the construct comprises SEQ ID NO:16 or SEQ ID NO: 17.

26. A transgenic plant cell comprising in its genome the recombinant DNA construct of claim 25.

27. A transgenic plant containing the transgenic plant cell of claim 26.

28. Transgenic seed comprising in its genome the recombinant DNA construct of claim 25.

29. The recombinant DNA construct of claim 24, further comprising SEQ ID NO: 20, SEQ ID NO: 27 or SEQ ID NO: 35.

Details for Patent 8,404,927

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.